ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0597

Telemedicine in Pediatric Rheumatology During COVID-19: The PR-COIN Experience

Y. Ingrid Goh1, Nancy Pan2, Julia Harris3, Andrew Warmin4, Janalee Taylor4, Sheetal Vora5, Fatima Barbar-Smiley6, Jon Burnham7, Tzielan Lee8, Cagri Yildirim-Toruner9, Kendra Wiegand10 and Esi Morgan11, 1The Hospital for Sick Children, Toronto, ON, Canada, 2Hospital for Special Surgery, New York, NY, 3Children's Mercy Kansas City, Overland Park, KS, 4Cincinnati Children's Hospital, Cincinnati, OH, 5Atrium Health Levine Children's Hospital, Charlotte, NC, 6Nationwide Children's Hospital/The Ohio State University, Columbus, OH, 7Children's Hospital of Philadelphia, Philadelphia, PA, 8Stanford University School of Medicine, Palo Alto, CA, 9Nationwide Children's Hospital, Houston, TX, 10Cincinnati Children's Hospital, Cincinnati, 11Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

Meeting: ACR Convergence 2020

Keywords: Access to care, COVID-19, Health Care, Health Services Research, Pediatric rheumatology

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 7, 2020

Title: Health Services Research Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Healthcare teams were forced to rethink the way they practiced medicine during the COVID-19 pandemic. Many teams transitioned from conducting in-person visits to virtual telemedicine visits with limited knowledge, experience with, or infrastructure for telemedicine. PR-COIN, a quality improvement collaborative of 20 North American pediatric rheumatology centers, set out to capture the experience of the rapid adoption of telemedicine, understand its usage and acceptability, and gather opinions on its continued use.

Methods: A REDCap® survey was sent to a representative from each PR-COIN site to collect data about their experience with telemedicine and its use during COVID-19. Quantitative data were analyzed using descriptive statistics and qualitative data were thematically analyzed.

Results: 19/20 of the PR-COIN sites responded to the survey. All sites transitioned from in-person to virtual telemedicine visits during the COVID-19 state of emergency (Figure 1). Most centers reported using both videoconferencing system and telephone to conduct their telemedicine visits (Table 1). All centers reported seeing both new consultations and follow up patients over telemedicine.

13/19 (68%) reported at least 50% of their providers consistently used pediatric Gait Arms Legs and Spine (PGALS) to document musculoskeletal exams in patients with juvenile idiopathic arthritis (JIA). Items that were not well-documented during telemedicine visits included: weight, height, disease activity, and treatment targets. 11/19 (58%) centers reported collecting patient global assessment, pain intensity and morning stiffness during the telemedicine visits. Two sites indicated they did not collect any patient reported outcome measures (PROMs), while three indicated they collected more complex PROMs.

7/19 (37%) centers reported performing research-related activity during telemedicine visits. 2/7 (29%) reported the ability to consent patients over telemedicine and 6/7 (86%) reported performing follow-up visits for observational studies.

All responding PR-COIN centers agreed that telemedicine visits were able to meet provider needs and the providers from all but one center believed that telemedicine visits were able to meet patient needs. Reasons to justify an in-person visit included presence of active disease, worsening of condition, and parent request/desire.

Identified benefits of telemedicine visits included convenience, no travel, and continuity of care for families who were hesitant to have an in-person visit. Identified challenges with telemedicine visits included limited ability to perform physical exams, difficulty assessing disease activity, and access to technology.

All centers supported the continued use of telemedicine after the pandemic. Centers indicated that they would be willing to see both new [15/19 (79%)] and follow up [14/19 (74%)] patients over telemedicine.

Conclusion: Healthcare providers have recognized the potential of incorporating telemedicine into their routine practice to serve a portion of their patients. PR-COIN plans on identifying best practices and creating tools to address existing barriers.

Figure 1. Use of Telemedicine Over Time

Table 1. Mediums Used to Conduct Virtual Telemedicine Visits


Disclosure: Y. Goh, None; N. Pan, None; J. Harris, None; A. Warmin, None; J. Taylor, None; S. Vora, None; F. Barbar-Smiley, None; J. Burnham, None; T. Lee, None; C. Yildirim-Toruner, None; K. Wiegand, None; E. Morgan, None.

To cite this abstract in AMA style:

Goh Y, Pan N, Harris J, Warmin A, Taylor J, Vora S, Barbar-Smiley F, Burnham J, Lee T, Yildirim-Toruner C, Wiegand K, Morgan E. Telemedicine in Pediatric Rheumatology During COVID-19: The PR-COIN Experience [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/telemedicine-in-pediatric-rheumatology-during-covid-19-the-pr-coin-experience/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/telemedicine-in-pediatric-rheumatology-during-covid-19-the-pr-coin-experience/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology